Tag:

HR

Naples Blocks Eintracht Frankfurt Tickets for Champions League Game

by Alex Carter - Sports Editor September 25, 2025

written by Alex Carter - Sports Editor

Naples Bans Eintracht frankfurt Fans From Champions⁢ League Match Amidst Security Concerns

Naples,Italy – September 24,2025,7:24 AM EST – In a move sparking outrage from Eintracht Frankfurt officials,the ⁤Prefect‍ of naples has prohibited the sale of away tickets to Eintracht Frankfurt supporters⁤ for the Champions League match against ⁣SSC Naples on⁣ November 4th. This is ‍the second time⁢ authorities have ⁢taken action impacting‍ Eintracht fans, raising concerns about fairness and fan safety.

The decision, announced ⁢Tuesday afternoon by ‍Prefect Michele di Bari, comes on ⁣the suggestion of the Naples police force. authorities cite significant security concerns ‍stemming from the potential for clashes⁢ between supporters of both ⁤clubs.

Eintracht frankfurt board member Philipp Reschke expressed his ⁢anger‍ at ‌the ban, signaling a⁢ strong response⁤ from⁣ the German club.

This developing story will be updated as more facts becomes available.

Keywords: Eintracht Frankfurt,SSC Naples,Champions League,Football,Soccer,Naples,Italy,Away Tickets,Fan Ban,Security Concerns,Philipp‍ Reschke,Michele di Bari.

September 25, 2025 0 comments

Technology

Lecturer in Blockchain Technology – ATU Donegal Job Description

by Rachel Kim – Technology Editor September 11, 2025

written by Rachel Kim – Technology Editor

ATU Donegal⁤ Announces Lecturer Position in Computing with Focus⁤ on Blockchain Technology

letterkenny, Ireland – ⁣Atlantic Technological University (ATU)⁤ Donegal is seeking a dynamic and experienced Lecturer to join ⁤its Department of computing within the Faculty of Engineering & Technology. This is an exciting prospect to contribute to a growing and innovative program portfolio⁢ focused on industry relevance and ⁤professional practice.

The accomplished candidate will be based at‌ ATU Donegal’s Letterkenny Campus and will primarily deliver instruction on campus, with potential for blended and project-based learning incorporating online elements by agreement. The Department fosters a collaborative⁤ learning⁢ surroundings,and the Lecturer will join ‌an enthusiastic team engaged in shared modules across various disciplines.ATU⁢ Donegal is committed to the professional development of its faculty, actively encouraging pedagogic staff development and supporting opportunities for further qualification progression.

Key Responsibilities:

‌Deliver high-quality teaching in Computing, with a strong emphasis on Blockchain Technology.
⁤ Contribute to the development ‌and implementation of innovative‍ curricula.
Engage in collaborative learning initiatives with colleagues across ⁤the department.
Potentially supervise undergraduate and⁣ postgraduate research projects.

Essential qualifications:

A master’s Degree (Level‍ 9 NFQ or equivalent) in a relevant field. A minimum of ⁤three years of‍ relevant post-qualification experience.

desirable qualifications:

While not required, the ‌following qualifications⁣ would be considered a⁣ significant advantage:

Blockchain⁢ Expertise: Extensive knowledge and practical⁢ experience with Blockchain Technology.
Advanced Degree: A postgraduate qualification, preferably a PhD.
Teaching Experience: ‌ Prior ⁤experience teaching at the third level, both online and in-person.
Research Background: Demonstrated research experience.
Curriculum Development: Experience in⁢ the development and implementation of academic programs.
Soft Skills: ‌ A flexible, adaptable, and team-oriented individual with excellent communication, organizational, and interpersonal skills,‌ and a proven ability to teach effectively.

To Apply:

Interested candidates are encouraged to apply through the ATU⁢ careers portal[[[[(Note: ⁢I cannot provide a⁢ link as it wasn’t in the source material.This would⁢ be added here⁢ in a live article)].

This position represents a fantastic opportunity to shape⁣ the future of computing ‌education at‌ a thriving ⁣technological university ⁣in the heart of Donegal.—

SEO Considerations:

Keywords: Blockchain, Lecturer, ATU Donegal, Computing, Higher Education, ‌Ireland,‌ Letterkenny, Faculty of Engineering & Technology, Teaching Jobs,⁣ Academic Jobs.
Meta description: ATU Donegal is hiring ‍a Lecturer in Computing⁤ with a ‌focus‍ on Blockchain Technology. Learn about the essential and desirable qualifications ‌and apply today!
Image Alt Text: ATU Donegal Letterkenny campus (if an image is used).
Internal Linking: ⁣Link to other relevant pages on world-today-news.com (if applicable) and to the ATU Donegal website.

September 11, 2025 0 comments

Health

Abemaciclib Improves Overall Survival in High-Risk Breast Cancer Patients

by Dr. Michael Lee – Health Editor September 3, 2025

written by Dr. Michael Lee – Health Editor

Abemaciclib Combination Therapy⁤ Demonstrates Overall Survival Benefit in High-Risk⁤ Breast‌ Cancer

New data reveal that abemaciclib, when combined with endocrine therapy (ET), considerably‍ improves overall survival in patients with node-positive, high-risk, hormone ⁣receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) early breast cancer.Findings released August 27, 2025, by Eli Lilly and Company⁣ demonstrate a survival benefit with two ‌years of therapy.

Breast cancer is the⁢ second most diagnosed cancer ‌globally and ‍a leading cause of‌ cancer-related death, responsible for nearly 666,000⁢ deaths in 2022. Approximately 70% ‍of all breast cancer cases are HR+,HER2-,meaning ‍the tumor relies on⁢ estrogen and progesterone,and does not overexpress the HER2 protein.⁢ While early-stage HR+/HER2- breast cancer has a favorable prognosis, high-risk patients-those with positive nodal status, multiple positive nodes, large⁣ tumor‍ size, or high⁢ tumor ⁢grade-are three times more likely to experience ⁤recurrence.

Abemaciclib, a ‍CDK4/6 ⁣inhibitor, received FDA approval in March 2023 for expanded use⁤ in the adjuvant treatment of high-risk, HR+/HER2- early breast cancer when combined with ET. It was the first CDK4/6 ‌inhibitor approved⁤ for this indication.

The drug ‌is available as‍ an oral tablet in dosages of 50 mg, 100 mg, 150 mg, and 200 ‌mg, administered twice daily. Beyond early-stage disease, ‌abemaciclib is also indicated for advanced or metastatic breast cancer, both ‌as a first-line treatment alongside an aromatase inhibitor and in combination with⁣ fulvestrant for patients whose disease has progressed after prior ET. It can also be used as a single⁤ agent for advanced or metastatic disease ‌following progression after both⁤ ET and chemotherapy.

“These data validate [abemaciclib] as the standard-of-care ‍for patients with node-positive, ⁣high-risk disease and increase the ‌urgency ⁤to ensure all eligible patients are treated,” stated Naarden ‍in the Lilly⁣ news release.

REFERENCES

Lilly’s Verzenio® (abemaciclib) increases overall survival in‍ HR+, HER2-, high-risk early breast cancer with two years of therapy. Eli Lilly and Company. News release. August 27, 2025. Accessed September 2,‍ 2025. https://www.prnewswire.com/news-releases/lillys-verzenio-abemaciclib-increases-overall-survival-in-hr-her2–high-risk-early-breast-cancer-with-two-years-of-therapy-302539340.html
A Study of Nonsteroidal Aromatase inhibitors ⁤Plus Abemaciclib ‍(LY2835219) in Postmenopausal women‌ With Breast cancer (MONARCH 3) Updated April 20, 2024. Accessed September 2, 2025. https://clinicaltrials.gov/study/NCT02246621
FDA expands early breast cancer indication for abemaciclib with endocrine therapy. FDA. News release. March 3, 2023. Accessed September 2, 2025. https://www.fda.gov/drugs/resources-details-approved-drugs/fda-expands-early-breast-cancer-indication-abemaciclib-endocrine-therapy

September 3, 2025 0 comments

Business

Title: Breast Cancer Drug Extends Life Expectancy by Seven Years

by Priya Shah – Business Editor August 31, 2025

written by Priya Shah – Business Editor

Breakthrough Drug Extends Life Expectancy for Early-Stage Breast Cancer Patients, New Data Suggests

Jakarta, ⁢Indonesia – A new drug is showing remarkable promise in extending the⁤ lives of patients with early-stage breast cancer, potentially adding up to seven years to‍ their life expectancy. Pharmaceutical company ‌Lilly Oncology reports that late-stage clinical trial results for the drug, abemaciclib – sold under ⁤the brand name Verzenio⁤ – demonstrate a significant ⁤reduction in recurrence risk for certain types⁢ of breast cancer that ‌have spread to lymph nodes.The findings, ⁤initially reported by ScienceAlert on August 31, 2025, are based⁤ on a seven-year follow-up⁢ study. While the data is currently awaiting peer review, Lilly Oncology has committed to presenting the full results at an upcoming medical conference and has submitted the research for publication.

“This data‌ solidifies‌ Verzenio’s position as ⁣a standard of‌ care for high-risk patients with node-positive disease ⁤and underscores⁣ the urgent need to ensure all eligible patients⁢ have access to this ⁢treatment,” ⁣stated jacob Van Naarden, Director of ⁢Lilly Oncology.

Approved by the‌ U.S. Food⁣ and Drug management (FDA) in 2017,⁢ Verzenio ‍is an oral medication

August 31, 2025 0 comments

Business

UK HR Leaders Face Major Challenges in 2025: Key Trends and Quotes

by Priya Shah – Business Editor August 1, 2025

written by Priya Shah – Business Editor

Here are seven quotes that reflect the challenges senior HR leaders have faced in the first half of 2025, according to the provided text:

“Businesses could face a challenging spike in HR turnover at a time when they want their teams performing at their best.” (This quote highlights the potential for increased HR staff leaving their roles, impacting business performance.)

“We’re at a point with AI where there are more questions than answers. We do not have the playbook for what it means to bring AI into our workforce.” (This quote points to the uncertainty and lack of established best practices surrounding AI integration in the workplace.)

“We want AI to be in service of people, not just in service of the business.” (This quote, from Sarah Franklin, CEO of Lattice, addresses the concern about AI’s impact on human workers and emphasizes a people-centric approach.)

“It’s easy to make a statement about diversity and inclusion. The real work, however, is to hold yourself accountable for making progress.” (This quote underscores the challenge of moving beyond rhetoric to tangible action in diversity and inclusion efforts.)

The text also mentions that “over half (52%) of HR professionals have experienced burnout as the pandemic,” and Lenke Taylor,Chief People Officer at Personio,states that “businesses must increase investment in the function if it is indeed to achieve its strategic goals of creating an engaging,rewarding and productive work environment.” while these are statements about the situation, they are not presented as direct quotes from specific HR leaders within the provided snippets.

August 1, 2025 0 comments

Technology

Oxford Robotics Postdoc: Exciting New Opportunity

by Chief editor of world-today-news.com June 7, 2025

written by Chief editor of world-today-news.com

Oxford University Seeks Robotics Researcher to Revolutionize Sports Medicine

The University of Oxford is seeking a full-time Postdoctoral Researcher in Robotics to contribute to groundbreaking work at The Podium Institute for Sports medicine and Technology.

Advancing Sports Injury Prevention with Robotics

The Podium Institute, supported by a £25 million donation, aims to develop and validate new technologies for the diagnosis, prevention, and management of sports injuries. The focus is on safety, not just performance. The institute is located within the Institute of Biomedical Engineering (IBME) in the University’s Department of Engineering Science, Old road Campus Research Building, Headington OX3 7DQ.

The researcher will join an interdisciplinary team to develop cutting-edge robotics and AI technologies to understand and respond to human behavior in real-time and long-term contexts. A key responsibility will be the testing and design of novel personal protection equipment (PPE).

Responsibilities and Qualifications

The role involves developing a new robotic benchmarking testing setup, hardware and controller of a robotic mechanical impactor, and a data acquisition system with integrated sensors.

Candidates should hold or be near completion of a PhD/DPhil in Robotics, Biomedical Engineering, Facts Engineering, Electrical Engineering, Computer Science, or a related field. They should also have a good track record of robotic publications/presentations in the field of healthcare, specialist knowledge in mechatronics design and control, and programming experience in Python, MATLAB, or C/C++.

How to Apply

applications must be received before midday on July 7, 2025. Applicants are required to upload a covering letter/supporting statement, including a brief statement of research interests, a CV, and the details of two referees.

For more information about working at the Department, visit www.eng.ox.ac.uk/about/work-with-us/.

Frequently Asked Questions

What is the duration of the position?

The post is initially fixed-term for 12 months with possible extension.

Where is the position located?

The position is located at the Department of Engineering Science, Institute of Biomedical Engineering, Old Road Campus research Building, Headington OX3 7DQ.

Who can I contact for informal inquiries?

Informal inquiries may be addressed to Professor Liang He (email: liang.he@eng.ox.ac.uk).

June 7, 2025 0 comments

Newer Posts

Older Posts